Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Eye irritation

Currently viewing:

Administrative data

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Well documented study following standard guidelines and performed following GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1995

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Fatty acids, C10-20-neo-
EC Number:
285-549-6
EC Name:
Fatty acids, C10-20-neo-
Cas Number:
85116-96-7
Molecular formula:
C10H20O2 ... C20H40O2
IUPAC Name:
C10-20-neo-Fatty acids
Details on test material:
- Name of test material (as cited in study report): Versatic 1019
- Substance type: brown liquid

Test animals / tissue source

Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Harlan Olac Limited
- Age at study initiation: young adult
- Weight at study initiation: 2440-2790 g
- Housing: individually in aluminum cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 14 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 +/- 1
- Humidity (%): 45
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): 12/12

Test system

Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent no treatment
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 ml
- Concentration (if solution): n/a
Duration of treatment / exposure:
Material was instilled into the eye and held shut for one second
Observation period (in vivo):
1 h, 24 h, 48 h, 72 h after treatment
Number of animals or in vitro replicates:
3 rabbits
Details on study design:
SCORING SYSTEM: Draize


TOOL USED TO ASSESS SCORE: hand-slit lamp / biomicroscope / fluorescein

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
conjunctivae score
Basis:
mean
Time point:
other: 1 hour
Score:
4
Reversibility:
fully reversible within: 72 hours
Remarks on result:
other: 4 out of 10
Irritation parameter:
conjunctivae score
Basis:
mean
Time point:
other: 24 hours
Score:
0.67
Reversibility:
fully reversible within: 72 hours
Remarks on result:
other: 0.67 out of 10
Irritation parameter:
conjunctivae score
Basis:
mean
Time point:
other: 48 hours
Score:
0.33
Reversibility:
fully reversible within: 72 hours
Remarks on result:
other: 0.33 out of 10
Irritation parameter:
cornea opacity score
Basis:
mean
Time point:
other: 1, 24, 48, and 72 hour average
Score:
0
Max. score:
0
Irritation parameter:
iris score
Basis:
mean
Time point:
other: 1, 24, 48, and 72 hour averages
Score:
0
Max. score:
0

Applicant's summary and conclusion

Interpretation of results:
slightly irritating
Remarks:
Migrated information
Conclusions:
Under the conditions of the study, Versatic 1019 was considered slightly, but transiently, irritating to the rabbit eye.
Executive summary:

Versatic 10 (neodecanoic acid) was tested for eye irritancy in one eye of each of three rabbits. Eye responses were scored at 1, 24, 48, and 72 hours after treatment according to the method of Draize. At 1 hour after treatment, animals showed slight redness of the conjunctivae, and severe discharge. In all animals, recovery was advanced by 48 hours after treatment and the remaining eye responses had resolved completely by 72 hours after treatment.